[Advance in immunotherapy on biliary tract cancers].

Liu, L G; Zhang, Y J; Wang, X A; Liu, Y B

Liu, L G; Zhang, Y J; Wang, X A; Liu, Y B.

Affiliation

Liu LG; Department of Biliary-Pancreatic Surgery,Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine;Shanghai Key Laboratory of Biliary Tract Disease Research; Shanghai Research Center of Biliary Tract Disease; State Key Laboratory for Oncogenes and Related Genes,Shanghai 200127,Ch
Zhang YJ; Department of Biliary-Pancreatic Surgery,Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine;Shanghai Key Laboratory of Biliary Tract Disease Research; Shanghai Research Center of Biliary Tract Disease; State Key Laboratory for Oncogenes and Related Genes,Shanghai 200127,Ch
Wang XA; Department of Biliary-Pancreatic Surgery,Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine;Shanghai Key Laboratory of Biliary Tract Disease Research; Shanghai Research Center of Biliary Tract Disease; State Key Laboratory for Oncogenes and Related Genes,Shanghai 200127,Ch
Liu YB; Department of Biliary-Pancreatic Surgery,Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine;Shanghai Key Laboratory of Biliary Tract Disease Research; Shanghai Research Center of Biliary Tract Disease; State Key Laboratory for Oncogenes and Related Genes,Shanghai 200127,Ch

Zhonghua Wai Ke Za Zhi ; 59(2): 156-160, 2021 Feb 01.

Article in Zh | MEDLINE | ID: mdl-33378809

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Duct Neoplasms / Biliary Tract Neoplasms / Cholangiocarcinoma / Immunotherapy Type of study: Prognostic_studies / Screening_studies Limits: Humans Language: Zh Journal: Zhonghua Wai Ke Za Zhi Year: 2021 Document type: Article Affiliation country: Suiza

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google